Recombinant DLL3 (Rovalpituzumab Biosimilar) antibody

Catalog No. ABIN7093083

This Humanized Monoclonal antibody specifically detects DLL3 (Rovalpituzumab Biosimilar) in FACS. It exhibits reactivity toward Human.

Quick Overview for Recombinant DLL3 (Rovalpituzumab Biosimilar) antibody (ABIN7093083)

Target: DLL3 (Rovalpituzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This DLL3 (Rovalpituzumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-DLL3 (Rovalpituzumab Biosimilar) Antibody

Purpose: Anti-DLL3 (Rovalpituzumab biosimilar) mAb

Characteristics: SC0001-SCX,SC0002,sc0001-SCX

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for DLL3 (Rovalpituzumab Biosimilar)

Target: DLL3 (Rovalpituzumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: SCDO1

UniProt: Q9NYJ7